Innovation Pharmaceuticals Inc (QB) (IPIX) Fundamentals

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Share Info
Market Cap$ 20,505,478
Shares Authorized600,000,000
Shares Outstanding488,225,673
Shares Outstanding Date07/01/2022
Shareholder Count68
Shareholder Count Date06/30/2020
Float Date03/31/2021
Short Interest486,608
Short Interest Date07/15/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorPinnacle Accountancy Group of Utah
Auditor Address1438 N. Highway 89, Suite 120
Farmington, Utah 84025
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselHogan Lovells US LLP
Legal Counsel Address875 Third Avenue
New York, New York 10022
Legal Counsel Website-
Fiscal Year End6/30
ADR Ratio-
Transfer AgentWest Coast Stock Transfer Inc.
Transfer Agent Address721 N. Vulcan Ave.
First Floor
Encinitas, CA 92024
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:IPIX
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0001355250
Address301 Edgewater Place
Suite 100
Wakefield, Massachusetts 01880
Phone(978) 921-4125
Fax #-
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesCEO - Leo Ehrlich
Dir. - Barry Schechter
Dir. - Zorik Spektor
Number of Employees4
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year2005

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.